Foundayo Tab 9mg x 30

Foundayo 9mg film-coated tablets contain orforglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It is a prescription-only medicine authorised in the UK for weight management in eligible adults and to improve glycaemic control in adults with insufficiently controlled type 2 diabetes.

Orforglipron activates GLP-1 receptors involved in appetite regulation and glucose metabolism. For weight management, it is used alongside a reduced-calorie diet and increased physical activity.

The 9mg strength is one of several available strengths and may be prescribed following gradual dose escalation, according to the patient's response, tolerability and clinical circumstances.

Delivery and Returns

SKU: SK-01067 Category: Tags: , Brands:

Benefits

  • Oral GLP-1 treatment: Contains orforglipron in tablet form.
  • Weight management: Used alongside appropriate dietary and physical activity measures in eligible adults.
  • Blood glucose control: Indicated for eligible adults with insufficiently controlled type 2 diabetes.
  • Once-daily formulation: Taken according to the prescribed treatment plan.
  • Flexible dose escalation: Forms part of a range of strengths that allows treatment to be individualised by a prescriber.

Features

  • Active ingredient: Orforglipron
  • Strength: 9mg per tablet
  • Pack size: 30 film-coated tablets
  • Administration: Oral
  • Dosing frequency: Once daily, as prescribed
  • Food restrictions: May be taken with or without food, at any time of day.
  • Treatment approach: Used alongside appropriate lifestyle measures.
  • Prescription status: Prescription-only medicine.

Why Choose

Foundayo provides an oral treatment option for eligible adults requiring medical management of weight or type 2 diabetes. Its active ingredient, orforglipron, acts on GLP-1 receptors involved in appetite regulation and glucose metabolism.

The 9mg strength can form part of an individually prescribed treatment plan following gradual dose escalation. The appropriate dose depends on treatment response, tolerability, other medicines and relevant clinical considerations.

Common Uses

Weight management: Used alongside a reduced-calorie diet and increased physical activity in eligible adults with an initial BMI of 30kg/m² or above, or a BMI of 27kg/m² to below 30kg/m² with at least one weight-related health condition.

Type 2 diabetes: Used alongside diet and exercise to improve blood glucose control in adults with insufficiently controlled type 2 diabetes. It may be prescribed alone or alongside other diabetes medicines, according to the authorised indication and individual clinical circumstances.

How It Works

Foundayo contains orforglipron, a non-peptide GLP-1 receptor agonist. It activates GLP-1 receptors involved in appetite regulation and glucose metabolism.

Its effects include reducing food intake, supporting weight reduction and improving blood glucose control. It also delays gastric emptying, with this effect generally diminishing over time.

Foundayo should be used only as prescribed and alongside the lifestyle measures recommended by the treating healthcare professional.

What is Foundayo 9mg used for?
Foundayo is authorised for weight management in eligible adults and to improve glycaemic control in adults with insufficiently controlled type 2 diabetes. It is used alongside appropriate diet and physical activity measures.
What is the active ingredient in Foundayo?
The active ingredient is orforglipron, an oral GLP-1 receptor agonist.
How is Foundayo 9mg taken?
Foundayo is taken orally once daily, at any time of day, with or without food. Tablets should be swallowed whole and must not be broken, crushed or chewed. Patients should follow their prescription instructions.
Is 9mg the starting dose?
No. Treatment begins at 0.8mg once daily, with dose increases considered after at least 30 days at each current dose. The 9mg strength should only be used as directed by the prescribing healthcare professional.

Related products